Traws Pharma (TRAW) investor Jorey Chernett discloses 6.8% stake in 13G

Rhea-AI Filing Summary

Traws Pharma, Inc. disclosed that individual investor Jorey Chernett has filed a Schedule 13G reporting a sizable ownership position in the company’s common stock. Chernett reports beneficial ownership of 543,268 shares of common stock, representing 6.8% of the class, based on the issuer’s outstanding shares. The filing states that Chernett has sole power to vote and dispose of all 543,268 shares, with no shared voting or dispositive authority.

The Schedule 13G is a filing type used for investors who characterize their holdings as passive. Consistent with that, Chernett certifies that the securities were not acquired and are not held for the purpose or effect of changing or influencing control of Traws Pharma, and are not part of any group or control-related arrangement.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Traws Pharma, Inc.

(Name of Issuer)

Common

(Title of Class of Securities)

68232V884

(CUSIP Number)

01/14/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 68232V884

1

Names of Reporting Persons

Chernett Jorey

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 543,268.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 543,268.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

543,268.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.8 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Traws Pharma, Inc.
(b)	Address of issuer's principal executive offices: 12 Penns Trail, Newtown, PENNSYLVANIA, 18940.
Item 2.
(a)	Name of person filing: Jorey Chernett
(b)	Address or principal business office or, if none, residence: 6222 Indianwood Trail, Bloomfield Hills, MI 48301
(c)	Citizenship: US
(d)	Title of class of securities: Common
(e)	CUSIP No.: 68232V884
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 543,268
(b)	Percent of class: 6.8%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 543,268
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 543,268
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/Jorey Chernett
Name/Title:	Individual
Date:	01/16/2026

FAQ

What percentage of Traws Pharma (TRAW) does Jorey Chernett report owning?

The Schedule 13G states that Jorey Chernett beneficially owns 6.8% of Traws Pharma’s common stock, based on the issuer’s outstanding shares.

How many Traws Pharma (TRAW) shares does Jorey Chernett beneficially own?

The filing reports that 543,268 shares of Traws Pharma common stock are beneficially owned by Jorey Chernett.

Does Jorey Chernett have sole or shared voting power over Traws Pharma (TRAW) shares?

The Schedule 13G indicates sole voting power over 543,268 shares and no shared voting power in Traws Pharma common stock.

Is Jorey Chernett part of a group regarding Traws Pharma (TRAW) ownership?

No. The ownership items note no group status, and there is no classification of any group or related entities for this holding.

Is the Traws Pharma (TRAW) stake held for control purposes?

No. Chernett certifies that the shares were not acquired and are not held to change or influence control of Traws Pharma, consistent with a passive Schedule 13G filing.

Who is the reporting person on this Traws Pharma (TRAW) Schedule 13G?

The reporting person is Jorey Chernett, a United States individual investor, filing as an “IN” type of reporting person.